Full document - International Hospital Federation
Full document - International Hospital Federation
Full document - International Hospital Federation
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Innovation and clinical specialities: oncology<br />
<strong>International</strong> Union Against Cancer) and the American Joint<br />
Committee on Cancer (AJCC). Tables 2 and 3 show the latest<br />
TNM staging for Breast Cancer (AJCC classification (6th edition or<br />
revision) 55 , which incorporates both clinical information and<br />
changes related to the growing use of new technology (e.g.,<br />
sentinel lymph node biopsy, immunohistochemical staining,<br />
reverse transcriptase-polymerase chain reaction). Patients with<br />
bilateral or multicentric breast cancer are staged according to the<br />
size of the largest tumor.<br />
Diagnosis<br />
Examination<br />
Early breast cancer causes no symptoms and is usually painless.<br />
The commonest symptom is a painless lump in the breast.<br />
Examination of the breast should be done in such a way to show<br />
respect for the privacy and comfort of the patient. A systematic<br />
approach to breast examination is important. Initial examination<br />
should start with the patient in an upright position with careful<br />
visual inspection of masses, skin and nipple changes, and<br />
asymmetries. Palpation should be done to include all the breast<br />
quadrants, the nipple-areola complex, the axillary tail and the<br />
axilla. Simple maneuvers like stretching the arms high above the<br />
head, tensing the pectoralis muscles may help accentuate<br />
asymmetries and dimpling.<br />
Other less frequent presenting signs and symptoms of breast<br />
cancer include (1) breast enlargement or asymmetry; (2) nipple<br />
changes, retraction, or discharge, including Paget’s disease; (3)<br />
ulceration or erythema of the skin of the breast including<br />
inflammatory carcinoma; (4) an axillary mass; and (5) systemic<br />
symptoms such as fatigue, cough, ascites or new musculoskeletal<br />
discomfort.<br />
Imaging<br />
Mammography, Ductography, Ultrasonography, MRI are imaging<br />
techniques useful in the screening and diagnosis of breast cancer.<br />
Mammography is the most useful test to differentiate between<br />
benign and malignant lesions and is the one that is recommended<br />
for breast cancer screening. Specific mammography features that<br />
suggest a diagnosis of a breast cancer include a solid mass with<br />
or without stellate features, asymmetric thickening of breast<br />
tissues, and clustered microcalcifications Mammography may also<br />
be used to guide interventional procedures, including needle<br />
localization and needle biopsy.<br />
Xeromammography techniques are identical to those of<br />
mammography with the exception that the image is recorded on a<br />
xerography plate, which provides a positive rather than a negative<br />
image Details of the entire breast and the soft tissues of the chest<br />
wall may be recorded with one exposure.<br />
Ductography and ductoscopy<br />
Mammary ductoscopy (MD) is a newly developed endoscopic<br />
technique that allows direct visualization and biopsy examination<br />
of the mammary ductal epithelium where most cancers originate.<br />
When combined with ductal lavage and cytology , it may reveal<br />
early carcinoma. 56-59 The primary indication for ductography is<br />
nipple discharge, particularly when the fluid contains blood.<br />
Radiopaque contrast media is injected into one or more of the<br />
major ducts and mammography is performed. Intraductal<br />
papillomas are seen as small filling defects surrounded by contrast<br />
media. Cancers may appear as irregular masses or as multiple<br />
intraluminal filling defects.<br />
Ultrasonography is an important method of resolving equivocal<br />
mammography findings, defining cystic masses, and demonstrating<br />
the echogenic qualities of specific solid abnormalities.<br />
Ultrasonography is used to guide fine-needle aspiration biopsy,<br />
core-needle biopsy, and needle localization of breast lesions. It is<br />
highly reproducible and has a high patient acceptance rate, but<br />
does not reliably detect lesions that are 1 cm or less in diameter<br />
Table 2: Diagnosis and pathology<br />
LEVEL OF RESOURCE CLINICAL PATHOLOGY IMAGING AND LABORATORY TESTS<br />
Basic History Interpretation of biopsies<br />
Physical examination<br />
Clinical breast examination<br />
Cytology or pathology report<br />
Surgical biopsy<br />
Fine-needle aspiration<br />
describe tumor size,<br />
lymph node staue,<br />
hiatologic type, tumor grade<br />
Limited Core needle biopsy Determination and reporting Diagnostic breast ultrassound+<br />
Image-guided sampling of ER and PR statue diagnostic mammography<br />
(ultrasonographic+mammographic)<br />
Plain chest mammography<br />
Determination and reporting<br />
Liver ultrasound<br />
of margin satue<br />
Blood chemistry profile/CBC<br />
Enhanced Preoperative needle localization under On-site cytopathologist Diagnostic mammography<br />
mammographic or ultrasound guidance<br />
Bone scan<br />
Maximal Stereotactic biopsy HER2/new statue CT scanning, PET<br />
Sentinal node biopsy IHC ataining of aentinel nodes MIBI scan, breast MRI<br />
for cytokeratin to detect<br />
micrometastaes<br />
CBC, coomplete bloodcount; CT, computed tomography; ER, estrogen recaptor; IHC, immunohistochemistry; MIBI, 99mto-sastamibi; MRI, magnetic resonance imaging;<br />
PET, positron emission tomography; PR, progerterone receptor<br />
94 <strong>Hospital</strong> and Healthcare Innovation Book 2009/2010